Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00474929
Status:
COMPLETED
Last Update Posted:
2019-08-20
First Post:
2007-05-16
Brief Title:
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma and Plasma Cell Neoplasm |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent adult grade III lymphomatoid granulomatosis | View |
| recurrent adult Hodgkin lymphoma | View |
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| stage III multiple myeloma | View |
| refractory multiple myeloma | View |
| Waldenström macroglobulinemia | View |
| recurrent adult Burkitt lymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| cutaneous B-cell non-Hodgkin lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |
| splenic marginal zone lymphoma | View |
| recurrent mycosis fungoidesSezary syndrome | View |